Clinical Research Directory
Browse clinical research sites, groups, and studies.
SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Summary
This is a prospective, single-arm, single-center phase I/II clinical trial evaluating the safety, objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) of simultaneous integrated boost accelerated hyperfractionated radiotherapy in patients with high-proliferation non-small cell lung cancer (NSCLC).
Official title: A Single-arm Phase I/II Clinical Study of Simultaneous Integrated Boost Accelerated Hyperfractionated Radiotherapy for High-proliferation Non-small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-06-16
Completion Date
2028-06-16
Last Updated
2026-09-16
Healthy Volunteers
No
Conditions
Interventions
hyperfractionated radiotherapy
simultaneous integrated boost accelerated hyperfractionated radiotherapy
Locations (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China